A network for stroke research in the Mid-Atlantic region
Stroke Central Atlantic Network for Research (SCANR)
This study is all about helping stroke patients in the Mid-Atlantic region by testing new treatments and ways to prevent strokes, and it's especially looking to include a diverse group of people, including African Americans, to make sure everyone benefits.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10993687 on NIH RePORTER |
What this research studies
The Stroke Central Atlantic Network for Research (SCANR) focuses on improving outcomes for stroke patients in the Mid-Atlantic region, particularly in areas with high stroke incidence. This initiative involves collaboration among several prestigious universities and hospitals to evaluate and enroll patients in various clinical trials related to acute stroke treatment, prevention, and rehabilitation. By screening and enrolling eligible patients, SCANR aims to advance knowledge and improve care for those affected by strokes. The network also emphasizes the inclusion of diverse populations, particularly African American patients, to ensure equitable research outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals experiencing acute strokes or those at risk of stroke, particularly in the Mid-Atlantic region.
Not a fit: Patients who have not experienced a stroke or are outside the targeted geographic area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and rehabilitation strategies for stroke patients.
How similar studies have performed: Previous research initiatives in stroke treatment and rehabilitation have shown promising results, indicating that this approach is built on a foundation of successful methodologies.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Turkeltaub, Peter Ethan — Georgetown University
- Study coordinator: Turkeltaub, Peter Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.